A Comparison of cryotherapy and imiquimod for treatment of actinic keratoses: Lesion clearance, safety, and skin quality outcomes

Journal of Drugs in Dermatology

Volumn 10, Issue 12, 2011, Pages 1432-1438

  Foley, Peter ^a,b,c   Merlin, Kate ^b   Cumming, Simon ^c   Campbell, Jan ^a,b   Crouch, Rohan ^c   Harrison, Shannon ^b   Cahill, Jennifer ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c SKIN AND CANCER FOUNDATION   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ACTINIC KERATOSIS; AGED; APPLICATION SITE BURNING; APPLICATION SITE VESICLE; ARTICLE; BLEEDING; BLISTER; CRYOTHERAPY; DRUG SAFETY; DRY SKIN; ERYTHEMA; EYE DISEASE; FACE; FEMALE; HEADACHE; HUMAN; HUMAN TISSUE; HYPOPIGMENTATION; INFECTION; MAJOR CLINICAL STUDY; MALE; PRURITUS; SCALP; SKIN ABRASION; SKIN CRUSTING; SKIN DEFECT; SKIN DISEASE; SKIN EDEMA; SKIN EXUDATE; SKIN FLAKING; SKIN PAIN; SKIN REDNESS; SKIN SCABBING; SKIN SCALING; SKIN SWELLING; SKIN WEEPING; SORE EYES;

ADJUVANTS, IMMUNOLOGIC; AGED; AMINOQUINOLINES; CRYOTHERAPY; FACIAL DERMATOSES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATOSIS, ACTINIC; MALE; SCALP DERMATOSES; TREATMENT OUTCOME;

EID: 84055199740     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Morton C, Campbell S, Gupta G, et al. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol. 2006;155:1029-1036. (Pubitemid 44564515)
2. Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol. 2002;47:258-262.
3. Freeman M, Vinciullo C, Francis D, et al. Photodynamic therapy using topical methyl aminolevulinate (Metvix®) gives better results than cryotherapy in patients with actinic keratosis. A prospective, randomized study. J Dermatol Treatment. 2003;14:99-106. (Pubitemid 36648700)
4. Krawtchenko N, Roewert-Huber J, Ulrich M, et al. A randomized study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow up. Br J Dermatol. 2007;157(suppl 2):34-40. (Pubitemid 350179628)
5. Gupta A, Davey V, Mcphail H. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies. J Cutan Med Surg. 2005;209-214. (Pubitemid 44265792)
6. Salasche S, Levine N, Morrison L. Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: an open label trial. J Am Acad Dermatol. 2002;47:571-577.
7. Olsen EA, Abernethy ML, Kulp-Shorten C, et al. A double-blind, vehicle- controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol. 1991;24:738-743.
8. Jorizzo J, Dinehart S, Matheson R, et al. Vehicle-controlled, doubleblind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head. J Am Acad Dermatol. 2007;57:265-268. (Pubitemid 47048863)
9. Research Randomizer. Social Psychology Network. Available at http:// www.randomizer.org/.
10. Aldara® (imiquimod cream, 5%) prescribing information, Graceway Pharmaceuticals, LLC, Bristol, TN, USA. November 2007.
11. RCT-Critical Appraisal sheet: Prepared by Centre for Evidence Based Medicines: University of Oxford 2005. Available at http://www.cebm. net/index.aspx?o=1157, Accessed February 2008.
12. Thai KE, Fergin P, Freeman M, et al. A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol. 2004;43:687-692. (Pubitemid 39276301)
13. Warino L, Tusa M, Camacho F, et al. Frequency and cost of actinic keratosis treatment. Dermatol Surg. 2006;32:1045-1049. (Pubitemid 44197455)
14. SID/AAD Monograph: The burden of skin diseases: 2005. Prepared by The Lewin Group, 2005. Available at http://www.lewin.com/NR/ rdonlyres/7C7F76FC- 3332-4FA0-BB27-61828ABDF401/0/april2005s-kindisease. pdf, Accessed August 2007.